Month: July 2018

IsoRay, Inc. Closes $8,250,000 Registered Direct Offering

The warrants have an exercise price of $0.75 per share of common stock, are exercisable commencing six months following the issuance date, and expire five and one-half years from the issuance date. 

IsoRay Announces $8.25 Million Registered Direct Offering

…announced that it has entered into definitive agreements with several institutional investors for the purchase in a registered direct offering of 11,000,000 shares of its common stock, at a purchase price of $0.75 per share, for gross proceeds of $8.25 million.

IsoRay Announces FDA Clearance of GammaTile™ Therapy for the Treatment of Recurrent Brain Neoplasms

IsoRay Medical, Inc., a wholly owned subsidiary of IsoRay, Inc., and GT Medical Technology had previously executed a collaborative development agreement and an exclusive ten-year supply agreement for GammaTile Therapy.

Scroll to top